Diagnostic HER2-binding radiopharmaceutical, [<sup>68</sup>Ga]Ga-ABY-025, for routine clinical use in breast cancer patients.Irina Velikyan, Jens Nørkær Sørensen, Joachim Feldwisch et al.|PubMed|2019Cited by 38